Crystalline forms of 5-(4-cyclopropyl-1H-imidazol-1-yl)-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-2-fluoro-4-methylbenzamide (Compound I) were prepared and characterized in the solid state: Also provided are processes of manufacture and methods of using the crystalline forms.
本发明提供了5-(4-环丙基-
1H-咪唑-1-基)-N-(6-(
4-异丙基-4H-1,2,4-三唑-3-基)
吡啶-2-基)-2-
氟-4-
甲基苯甲
酰胺(化合物I)的晶体形式,并在固态下进行了表征。同时,还提供了制造方法和使用晶体形式的方法。